跳至主要内容
临床试验/NCT05885958
NCT05885958已完成不适用

Timing of Active Void Trials After Urogynecologic Procedures

University of South Florida1 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2023年7月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
231
试验地点
1
主要终点
Pass Rate

研究概览

简要总结

The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogynecologic surgery.

Patient will be randomized to two arms prior to scheduled surgery. During the active void trial, women will be allotted up to 30 minutes or up to 60 minutes to void depending on respective randomization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Women undergoing a urogynecologic surgery at Tampa General Hospital and who are seen preoperatively at the University of South Florid Urogynecology clinic
  • •Women undergoing a urogynecologic surgery where a postoperative active void trial is indicated
  • •Planned for same day surgery
  • •Women able to consent for themselves
  • •Speak English and/or Spanish as preferred language

排除标准

  • •Imprisoned patients
  • •Females under the age of 18 years old
  • •Women who are unable or unwilling to consent to participation
  • •Women who are planning to stay inpatient overnight
  • •Women with history of urinary retention or neurogenic bladder
  • •Women undergoing procedure that is not standard of care to perform a void trial (includes sacral neuromodulation, botox to the pelvic floor, cystoscopy with hydrodistension, urethral bulking, etc)

研究组 & 干预措施

Immediate

Experimental

Patients will be given up to 30 minutes to void during the active void trial postoperatively.

干预措施: Time (Other)

Extended

Experimental

Patients will be given up to 60 minutes to void during the active void trial postoperatively.

干预措施: Time (Other)

结局指标

主要结局

Pass Rate

时间窗: 60 minutes

to compare the active void trial pass rate between arms

次要结局

  • Time in PACU(6 hours)
  • Pass Rate After Failing(60 minutes)
  • UTI(2 weeks)
  • Surgical Procedures Performed Prior to Active Void Trial(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Simone Fertel

Primary Investigator

University of South Florida

研究点 (1)

Loading locations...

相似试验